Silence Therapeutics plc Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2023 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Silence Therapeutics plc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2023 to Q4 2024.
  • Silence Therapeutics plc Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2024 was $157K, a 57.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $157K -$213K -57.6% Dec 31, 2024 10-K 2025-02-27
Q4 2023 $370K Dec 31, 2023 10-K 2025-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.